Dr Daniel Davis, | |
205 N Vine St, El Dorado, KS 67042-2055 | |
(316) 321-5330 | |
Not Available |
Full Name | Dr Daniel Davis |
---|---|
Gender | Male |
Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
Location | 205 N Vine St, El Dorado, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831555333 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 1-14485 (Kansas) | Secondary |
1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 1-14485 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Daniel Davis, 205 N Vine St, El Dorado, KS 67042-2055 Ph: (316) 321-5330 | Dr Daniel Davis, 205 N Vine St, El Dorado, KS 67042-2055 Ph: (316) 321-5330 |
News Archive
A drug that removes excess iron and toxins from the body after a brain bleed did not show significant improvement in recovery or neurological function at three months after intracerebral hemorrhage (stroke), but showed some benefits at six months, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.
Penn State has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Consuelo De Moraes, associate professor of entomology, titled "Scent of Disease: Diagnostic for Malaria Infection in Humans."
The court's online order did not offer any legal reasoning, nor were dissenting opinions noted. However, Justice Elena Kagan did participate in the decision. Meanwhile, Politico Pro explores some of the key questions that will be at stake surrounding the law's "individual mandate" as the challenges now wind through through the federal appeals courts this summer.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that on Friday, October 29, 2010 it submitted a complete response to the "Complete Response" letter issued by the U.S. Food and Drug Administration (FDA), regarding its supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for Injection for treatment of patients with advanced metastatic colorectal cancer.
A team of University of Wisconsin-Madison researchers reports that it has created induced human pluripotent stem (iPS) cells completely free of viral vectors and exotic genes.
› Verified 1 days ago
Martha Jean Tymony, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 S Village Rd, El Dorado, KS 67042 Phone: 316-322-8901 | |
Alaa Samaro, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 119 W 6th Ave, El Dorado, KS 67042 Phone: 316-519-2614 | |
Austin Michael Chinberg, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 720 W Central Ave, El Dorado, KS 67042 Phone: 316-321-3300 | |
Steven Vuong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 N Main St, El Dorado, KS 67042 Phone: 316-321-0318 Fax: 316-321-8810 | |
Jacob Milbradt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 N Vine St, El Dorado, KS 67042 Phone: 316-321-5330 Fax: 316-321-1254 | |
Dr. Luanna Thomas, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 720 W Central Ave, El Dorado, KS 67042 Phone: 316-322-4560 | |
Rachel Markovich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 N Main St, El Dorado, KS 67042 Phone: 316-321-0318 |